Medicines for Malaria Venture
Impact in
-
- Malaria Research and Control
- Mosquito-borne diseases and control
- Research on Leishmaniasis Studies
- Parasitology top 10%
- Parasites and Host Interactions
Papers in
-
- Malaria Research and Control 361
- Mosquito-borne diseases and control 112
- Research on Leishmaniasis Studies 35
- Parasitology 45
- Parasites and Host Interactions 31
- Top scholars
- Timothy N. C. WellsRobert G. RidleyJeremy N. BurrowsDidier LeroyRob Hooft van HuijsduijnenStephan DuparcDavid A. FidockSolomon Nwaka
- Journals
- Malaria Journal (91 papers)Antimicrobial Agents and Chemotherapy (41 papers)Journal of Medicinal Chemistry (25 papers)PLoS ONE (17 papers)ACS Infectious Diseases (14 papers)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Medicines for Malaria Venture
475 papers receiving 16.5k citations
Peers
Comparison fields: 5 of 185
- Public Health, Environmental and Occupational Health 10.7k
- Parasitology 1.7k
- Computational Theory and Mathematics 3.1k
- Pharmacology 1.2k
- Infectious Diseases 2.3k
Countries citing scholars working at Medicines for Malaria Venture
This map shows the geographic impact of research produced by authors working at Medicines for Malaria Venture. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Medicines for Malaria Venture with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Medicines for Malaria Venture more than expected).
Fields of papers published by authors at Medicines for Malaria Venture
This network shows the impact of papers affiliated with Medicines for Malaria Venture at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Medicines for Malaria Venture at the time of their publication.
About Medicines for Malaria Venture
In recent decades, authors affiliated with Medicines for Malaria Venture have published 526 papers, which have received a total of 17.8k indexed citations . Scholars at this organization have produced 386 papers in Public Health, Environmental and Occupational Health, 45 papers in Parasitology, 104 papers in Computational Theory and Mathematics, 78 papers in Infectious Diseases and 35 papers in Pharmacology on the topics of Malaria Research and Control (361 papers), Mosquito-borne diseases and control (112 papers), Computational Drug Discovery Methods (104 papers), HIV/AIDS drug development and treatment (53 papers), Research on Leishmaniasis Studies (35 papers), Parasites and Host Interactions (31 papers), Drug Transport and Resistance Mechanisms (29 papers) and Trypanosoma species research and implications (20 papers). Their work is cited by papers focused on Public Health, Environmental and Occupational Health (10.7k citations), Parasitology (1.7k citations), Computational Theory and Mathematics (3.1k citations), Pharmacology (1.2k citations) and Infectious Diseases (2.3k citations). Authors at Medicines for Malaria Venture collaborate with scholars in Switzerland, United States and United Kingdom and have published in prestigious journals including Malaria Journal, Antimicrobial Agents and Chemotherapy, Journal of Medicinal Chemistry, PLoS ONE and ACS Infectious Diseases. Some of Medicines for Malaria Venture's most productive authors include Timothy N. C. Wells, Robert G. Ridley, Jeremy N. Burrows, Didier Leroy, Rob Hooft van Huijsduijnen, Stephan Duparc, David A. Fidock, Solomon Nwaka, Jörg J. Möhrle and Wesley C. Van Voorhis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.